Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Neuraxis (NRXS) Cost of Revenue (2022 - 2025)

Neuraxis' Cost of Revenue history spans 4 years, with the latest figure at $762548.0 for Q3 2025.

  • For Q3 2025, Cost of Revenue rose 603.39% year-over-year to $762548.0; the TTM value through Sep 2025 reached $1.1 million, up 216.58%, while the annual FY2024 figure was $324708.0, 0.35% changed from the prior year.
  • Cost of Revenue for Q3 2025 was $762548.0 at Neuraxis, up from $142252.0 in the prior quarter.
  • Across five years, Cost of Revenue topped out at $762548.0 in Q3 2025 and bottomed at $64210.0 in Q3 2023.
  • The 4-year median for Cost of Revenue is $81589.0 (2022), against an average of $141731.6.
  • The largest annual shift saw Cost of Revenue decreased 26.8% in 2024 before it skyrocketed 603.39% in 2025.
  • A 4-year view of Cost of Revenue shows it stood at $65990.0 in 2022, then surged by 40.28% to $92569.0 in 2023, then decreased by 26.8% to $67759.0 in 2024, then soared by 1025.38% to $762548.0 in 2025.
  • Per Business Quant, the three most recent readings for NRXS's Cost of Revenue are $762548.0 (Q3 2025), $142252.0 (Q2 2025), and $133954.0 (Q1 2025).